Drug intelligence / Profile preview

ICXP007

Development stage: Unknown
Lead developer: Intercytex
Administration: Topical

Overview

ICXP007 is an investigational therapy developed for the treatment of non-infected venous leg ulcers and chronic diabetic foot ulcers. It has been studied in combination with standard compression bandaging to promote healing of chronic skin ulcers. Clinical trials have evaluated its safety and efficacy, but detailed information about its mechanism of action, molecular target, or specific modality is not publicly available. The drug was tested in completed clinical trials for venous leg ulcers and diabetic foot ulcers[2][3][4][5][7].

Beyond the preview

Go deeper on ICXP007.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICXP007.

Explore the full profile